170 related articles for article (PubMed ID: 22593639)
1. The role of the androgen receptor in the development and progression of bladder cancer.
Li Y; Izumi K; Miyamoto H
Jpn J Clin Oncol; 2012 Jul; 42(7):569-77. PubMed ID: 22593639
[TBL] [Abstract][Full Text] [Related]
2. Promotion of bladder cancer development and progression by androgen receptor signals.
Miyamoto H; Yang Z; Chen YT; Ishiguro H; Uemura H; Kubota Y; Nagashima Y; Chang YJ; Hu YC; Tsai MY; Yeh S; Messing EM; Chang C
J Natl Cancer Inst; 2007 Apr; 99(7):558-68. PubMed ID: 17406000
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer.
Shiota M; Takeuchi A; Yokomizo A; Kashiwagi E; Tatsugami K; Kuroiwa K; Naito S
J Urol; 2012 Jul; 188(1):276-86. PubMed ID: 22608749
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
Hsieh TF; Chen CC; Ma WL; Chuang WM; Hung XF; Tsai YR; Lin MH; Zhang Q; Zhang C; Chang C; Shyr CR
Oncol Rep; 2013 Dec; 30(6):2917-22. PubMed ID: 24126741
[TBL] [Abstract][Full Text] [Related]
5. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
[TBL] [Abstract][Full Text] [Related]
8. Role of the androgen receptor in urothelial cancer.
Inoue S; Mizushima T; Miyamoto H
Mol Cell Endocrinol; 2018 Apr; 465():73-81. PubMed ID: 28652170
[TBL] [Abstract][Full Text] [Related]
9. Nur77 inhibits androgen-induced bladder cancer growth.
Wu J; Liu J; Jia R; Song H
Cancer Invest; 2013 Dec; 31(10):654-60. PubMed ID: 24299210
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Naito S
Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
[TBL] [Abstract][Full Text] [Related]
11. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
[TBL] [Abstract][Full Text] [Related]
12. The role of the androgen receptor in the development and progression of prostate cancer.
Jenster G
Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
[TBL] [Abstract][Full Text] [Related]
13. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
[TBL] [Abstract][Full Text] [Related]
14. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of the androgen receptor in bladder cancer.
Lombard AP; Mudryj M
Endocr Relat Cancer; 2015 Oct; 22(5):R265-77. PubMed ID: 26229034
[TBL] [Abstract][Full Text] [Related]
16. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.
Burnstein KL
J Cell Biochem; 2005 Jul; 95(4):657-69. PubMed ID: 15861399
[TBL] [Abstract][Full Text] [Related]
17. The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
Zhang Z; Xu Q; Huang X; Yang J; Xu Y; Zhang G
Int J Clin Exp Pathol; 2015; 8(9):10283-93. PubMed ID: 26617736
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor activation: a prospective therapeutic target for bladder cancer?
Mizushima T; Tirador KA; Miyamoto H
Expert Opin Ther Targets; 2017 Mar; 21(3):249-257. PubMed ID: 28064545
[TBL] [Abstract][Full Text] [Related]
19. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
